| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.7 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |